We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Grievances and disciplinary action at work can be solved by informal discussions, formal procedures, mediation, conciliation or arbitration.
The CMA has found Pennon’s purchase of Sumisho Osaka Gas Water UK (including its subsidiary Sutton and East Surrey Water), could harm Ofwat’s ability to make comparisons between water companies and carry out its statutory functions.
We remind healthcare professionals that accidental use of glucose-containing solutions as flush fluid for arterial lines may contaminate blood samples and result in falsely high glucose readings. This may lead to inappropriate insulin administration and subsequent hypoglycaemia. Healthcare professionals should...
How to apply for a grant for habitat creation using blended public and private funding.
Procurement options available from the Crown Commercial Service for the public sector.
Batches of some products made by Legency Remedies Pvt Ltd have been found to contain a bacteria called Ralstonia pickettii (R. pickettii). All potentially affected batches are being recalled following an MHRA investigation.
How a marketing authorisation holder should report a defect with a veterinary medicine.
Employees can raise a grievance at work when an informal solution is not possible - grievance procedure, mediation, meetings, appeals
Settle disputes between your charity's trustees, staff or members to avoid putting your charity’s funds and users at risk.
The recipients of this year's King's Awards for Enterprise announced
Novartis Pharmaceuticals UK Limited is recalling Adakveo 10 mg/ml concentrate for solution for infusion due to the benefit-risk balance of Adakveo no longer being considered favourable by the MHRA.
How to set what you’ll evaluate digital outcomes, digital specialists, user research participants and studio suppliers on.
This document outlines the plan for an initiative from the French and German governments to control small arms and light weapons in the Western Balkans.
Bristol-Myers Squibb Pharmaceuticals Limited has informed the MHRA that a potential product quality issue has been detected, relating to incomplete crimping of the metal crimp cap of OPDIVO 10mg/mL concentrate for solution for infusion (nivolumab) (1VLX10ML).
Information on enhancing communications resilience and how we work with telecommunication service providers to manage the risk of disruption to public networks.
Expert analysis of the challenges to a sustainable and scalable approach to international data transfers and proposed solutions.
Novartis Pharmaceuticals has informed the MHRA that the solvent (water for injections in ampoules) co-packed with the impacted batches of Simulect powder for injection, may contain glass fragments approximately 20 – 800 µm in size.
Find out about making imports of mixtures of urea and ammonium nitrate originating in Russia, Trinidad and Tobago and the US that are subject to registration.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.